SEGALL BRYANT & HAMILL, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1006378
CHICAGO, IL
Position in VRTX
as of Mar 31, 2026
· filed May 22, 2026
Position Value
$17,001,117
-$1,051,224 QoQ
Shares Held
38,073
-4.4% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 23.01893730465159.ToString("F0")%
Shared 0.ToString("F0")%
None 76.98106269534841.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SEGALL BRYANT & HAMILL, LLC holds $242,312,554 across 27 Biotechnology names. VRTX ranks #5 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTGX |
Protagonist Therapeutics, Inc
|
212,714 | $22,420,055 | |
| 2 | TECH |
BIO-TECHNE Corp
|
428,507 | $22,393,775 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
79,497 | $20,535,665 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
298,056 | $19,263,359 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
38,073 | $17,001,117 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
31,870 | $16,682,988 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
175,898 | $16,249,457 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
195,380 | $13,311,239 |
All Filings in VRTX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,001,117 | 38,073 | Shares | Sole | 2026-05-22 | |
| 2025-12-31 | $18,052,341 | 39,819 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $16,045,882 | 40,971 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $18,844,425 | 42,328 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $25,609,162 | 52,822 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $22,645,834 | 56,235 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $26,893,251 | 57,825 | Shares | Sole | 2024-11-08 | |
| 2023-06-30 | $308,273 | 876 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $271,590 | 862 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $248,928 | 862 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $249,583 | 862 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $242,902 | 862 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $224,956 | 862 | Shares | Sole | 2022-05-13 | |
| 2021-06-30 | $480,887 | 2,385 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $431,714 | 2,009 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $470,552 | 1,991 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $494,442 | 1,817 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $252,860 | 871 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $207,254 | 871 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||